Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

NCT00564187 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Irbesartan
DRUG: Irbesartan

Sponsor

Sanofi

Collaborators

[object Object]